Aeva Technologies, Inc. current report, 12 March 2021

完整文档

Aeva Technologies, Inc. Form 8-K Summary

Business Context and Reporting Period

Filed for events beginning March 12, 2021, following the completion of the business combination between InterPrivate Acquisition Corp. and Legacy Aeva, Inc. The combined company changed its name to Aeva Technologies, Inc. and ceased to be a shell company. This filing reports transaction completion, related governance and financing arrangements, management changes, and incorporation of Legacy Aeva financial information by reference.

Key Financial Metrics and Capitalization

  • PIPE financing completed at the closing: 28,168,478 newly issued common shares for aggregate proceeds of approximately $320.0 million, at purchase prices of $10.00, $11.50, or $16.00 per share, as applicable.
  • Approximately $242.8 million remained in the trust account immediately before closing after approximately $310,829 was paid to redeem 30,874 public shares at approximately $10.07 per share. The remaining trust funds were available for transaction expenses and general corporate purposes.
  • Approximately 211.0 million common shares were issued and outstanding immediately following the transactions; 0 preferred shares were outstanding.
  • The filing text does not provide clear consolidated revenue, net income or loss, operating cash flow, free cash flow, gross margin, operating margin, debt balance, or liquidity runway figures. Audited Legacy Aeva financial statements and management’s discussion and analysis are filed as Exhibits 99.2 and 99.3.
  • The Sponsor converted $1.5 million of working-capital loans into 150,000 common shares and 75,000 private-placement warrants.
  • Aeva had not paid cash dividends. Future dividends remain subject to Board discretion, financial condition, capital requirements, revenues and earnings, and potentially debt covenants.

Material Changes Versus the Prior Comparable Period

  • InterPrivate completed its merger with Legacy Aeva on March 12, 2021, creating the public operating company Aeva Technologies, Inc.
  • Legacy Aeva common stock, including shares issued upon conversion of preferred stock, converted into Company common stock at approximately 9.08 Company shares per Legacy Aeva share.
  • The Company’s common stock and warrants began trading on the NYSE under the symbols AEVA and AEVAW on March 15, 2021, subject to continued listing compliance.
  • InterPrivate’s public units separated into their component securities and ceased trading as units.
  • Management changed materially: Soroush Salehian Dardashti became Chief Executive Officer, Mina Rezk became President, Chief Technology Officer and Chairman, and Saurabh Sinha became Chief Financial Officer. The former InterPrivate executive officers resigned at closing.
  • Deloitte & Touche LLP replaced Marcum LLP as independent registered public accounting firm for the year ending December 31, 2021. Marcum reported no disagreements or reportable events, but its prior report included a going-concern explanatory paragraph.

Guidance, Outlook, Risks and Unusual Items

  • The filing provides no specific revenue, earnings, production, cash-burn or profitability guidance.
  • Management’s forward-looking statements address expected benefits of the transaction, growth, liquidity, strategy and market opportunities, but are subject to substantial uncertainty.
  • Key risks include maintaining NYSE listing, securities-price volatility, intense competition and regulation, execution and commercialization delays, inability to achieve profitability, retention of key employees, product liability and regulatory proceedings, intellectual-property protection, supplier and manufacturing constraints, COVID-19 effects, and the costs of operating as a public company.
  • Registration rights require the Company to register certain resale securities. Eligible holders may demand underwritten offerings when the expected offering price exceeds $30 million, subject to conditions.
  • Lock-ups generally apply for 180 days to specified Legacy Aeva holders and for up to one year to Sponsor securities, subject to stated exceptions and a market-price release condition for part of the Sponsor holdings.
  • The Board was established with seven authorized seats, initially five directors and two vacancies, and classified three-year terms. The founders retained specified director nomination rights while holding at least 5% of the outstanding common stock.
  • Transaction bonuses of $1.0 million each were awarded to Messrs. Dardashti and Rezk, and $100,000 to Mr. Sinha.

Investor Verification Items

  • Review Exhibits 99.2, 99.3 and 99.4 for Legacy Aeva historical results, liquidity, cash flows, risk disclosures and unaudited pro forma capitalization.
  • Confirm the final use of the approximately $242.8 million trust balance and the amount of transaction expenses deducted.
  • Reconcile the 211,042,833 shares outstanding with PIPE shares, redemptions, merger consideration, warrants, options and other potential dilution.
  • Review the Registration Rights and Lock-Up Agreement for potential future resale supply and timing.
  • Assess the going-concern disclosure in the prior Marcum report and whether the post-closing financing sufficiently addresses prior liquidity concerns.
  • Verify NYSE listing compliance and the terms of the Aeva 2021 Incentive Award Plan.
  • Note that the filing is dated March 12, 2021, while the accountant-change approval and filing signature are dated March 18, 2021; investors should verify the applicable event dates in the filed exhibits.